MXPA04005366A - Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros. - Google Patents

Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.

Info

Publication number
MXPA04005366A
MXPA04005366A MXPA04005366A MXPA04005366A MXPA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A
Authority
MX
Mexico
Prior art keywords
alpha
amino acids
chirally pure
salt
sulfonyl
Prior art date
Application number
MXPA04005366A
Other languages
English (en)
Spanish (es)
Inventor
Resnick Lynn
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46204648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04005366(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/014,304 external-priority patent/US6610734B2/en
Priority claimed from US10/166,896 external-priority patent/US6657070B2/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA04005366A publication Critical patent/MXPA04005366A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04005366A 2001-12-11 2002-11-26 Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros. MXPA04005366A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/014,304 US6610734B2 (en) 2000-12-13 2001-12-11 Heterocyclic sulfonamide inhibitors of beta amyloid production
US10/166,896 US6657070B2 (en) 2000-12-13 2002-06-11 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
PCT/US2002/038117 WO2003050062A2 (fr) 2001-12-11 2002-11-26 Production d'acides $g(a)-amines et d'acides $g(a)-amines n-sulfonyles chiralement purs

Publications (1)

Publication Number Publication Date
MXPA04005366A true MXPA04005366A (es) 2004-09-27

Family

ID=46204648

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005366A MXPA04005366A (es) 2001-12-11 2002-11-26 Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.

Country Status (7)

Country Link
EP (1) EP1461332A4 (fr)
JP (1) JP4615861B2 (fr)
AU (2) AU2002351170B8 (fr)
CA (1) CA2470111A1 (fr)
MX (1) MXPA04005366A (fr)
TW (1) TWI260316B (fr)
WO (1) WO2003050062A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436526C (fr) 2000-12-13 2010-10-19 Wyeth Inhibiteurs sulfonamides heterocycliques de la production de beta-amyloide
JP2006522126A (ja) 2003-03-31 2006-09-28 ワイス βアミロイド生産のフルオロ含有およびトリフルオロアルキル含有複素環スルホンアミド阻害物質およびその誘導体
AU2005207835A1 (en) 2004-01-16 2005-08-11 Wyeth Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
JP2009534385A (ja) 2006-04-21 2009-09-24 ワイス キラル的に純粋なアミノアルコール中間体、それらの誘導体の製造、及びそれらの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802981A1 (de) * 1988-02-02 1989-08-10 Basf Ag Verfahren zur reduktion reduzierbarer verbindungen
US5264577A (en) * 1992-04-22 1993-11-23 Warner-Lambert Company Cyclic amino acids and derivatives thereof
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
KR100336699B1 (ko) * 1992-08-25 2002-05-13 윌리암스 로저 에이 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine

Also Published As

Publication number Publication date
TWI260316B (en) 2006-08-21
WO2003050062A3 (fr) 2003-11-20
AU2009251195A1 (en) 2010-01-21
AU2002351170B2 (en) 2009-09-24
JP4615861B2 (ja) 2011-01-19
AU2002351170B8 (en) 2009-10-08
EP1461332A4 (fr) 2009-10-21
EP1461332A2 (fr) 2004-09-29
AU2002351170A1 (en) 2003-06-23
JP2005511727A (ja) 2005-04-28
WO2003050062A2 (fr) 2003-06-19
TW200306292A (en) 2003-11-16
CA2470111A1 (fr) 2003-06-19

Similar Documents

Publication Publication Date Title
US8217197B2 (en) Process for producing methionine
US8680329B2 (en) Process for preparation of α-ketoglutaric acid
CN110252395B (zh) 一种用于制备高纯度牛磺酸的催化剂及其应用
CN101973941A (zh) 一种制备对羟基苯海因的方法
JP2010507701A5 (fr)
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
CN104592064A (zh) 一种2-氨基苯酚-4-磺酰胺的合成方法
CN101830818A (zh) 一种无水甜菜碱的制备方法
MXPA04005366A (es) Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.
NO20080812L (no) Fremgangsmate for fremstilling av 4 β-amino-4'demetyl-4-4-desoksy podofyllotoksin
CN102093149A (zh) 一种促进氰基快速水解制备羧酸类化合物的方法
CN101723773B (zh) 高纯度n-乙酰-dl-氨基酸的制备方法
WO2013159742A1 (fr) Dispositif et procédé destinés à la préparation de dl-méthionine
CN106518840A (zh) 一种2‑氯噻吩‑5‑甲酸的合成方法
CN106008392B (zh) 一种抗癌药物达沙替尼的中间体的制备方法
CN106905262A (zh) 一种制备高纯度4‑羟乙基哌嗪乙磺酸的方法
CN102329286B (zh) 一种新的合成3-氧杂环丁酮的方法
CN104326989A (zh) 2-甲基-4-氨基-5-(氨基甲基)嘧啶的制备方法
CN113501771B (zh) 一种n-(2-氨乙基)甘氨酸衍生物的制备方法
CN110606811B (zh) 一种l-丝氨酸甲酯盐酸盐的合成方法
CN104178534B (zh) 一种以南极磷虾为原料制备l-酪氨酸的方法
CN110483336A (zh) 一种脲酶抑制剂乙酰氧肟酸的合成方法
CN101429136B (zh) 一种n-苄基羟胺及其盐酸盐的制备方法
CN103981248A (zh) 一种拆分外消旋亮氨酸的方法
CN103319376B (zh) 肌酸盐酸盐的制备方法

Legal Events

Date Code Title Description
FG Grant or registration